Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Eder

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancerPanos Fidias, Nathan A Pennell, Anthony L Boral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumorsCasey Cunningham, Leonard J Appleman, Miora Kirvan-Visovatti, et al.
Physical Review Letters|February 2, 2013
Path entanglement of continuous-variable quantum microwavesE P Menzel, R Di Candia, F Deppe, et al.
Cancer|November 1, 2006
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumorsDavid P Ryan, Bert H O'Neil, Jeffrey G Supko, et al.
Scientific Reports|April 25, 2018
Finite-time quantum entanglement in propagating squeezed microwavesK G Fedorov, S Pogorzalek, U Las Heras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancerJ P Eder, P W Kantoff, K Roper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignanciesM A Villalona-Calero, J P Eder, D L Toppmeyer, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Trials of 9-amino-20(S)-camptothecin in BostonJ P Eder, E Rubin, R Stone, et al.
Cancer|March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trialDeborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancerPanos Fidias, Nathan A Pennell, Anthony L Boral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumorsCasey Cunningham, Leonard J Appleman, Miora Kirvan-Visovatti, et al.
Physical Review Letters|February 2, 2013
Path entanglement of continuous-variable quantum microwavesE P Menzel, R Di Candia, F Deppe, et al.
Cancer|November 1, 2006
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumorsDavid P Ryan, Bert H O'Neil, Jeffrey G Supko, et al.
Scientific Reports|April 25, 2018
Finite-time quantum entanglement in propagating squeezed microwavesK G Fedorov, S Pogorzalek, U Las Heras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancerJ P Eder, P W Kantoff, K Roper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignanciesM A Villalona-Calero, J P Eder, D L Toppmeyer, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Trials of 9-amino-20(S)-camptothecin in BostonJ P Eder, E Rubin, R Stone, et al.
Cancer|March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trialDeborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Pageof 12